American Diabetes Association Scientific Sessions

SAN FRANCISCO — The ED is a novel location to find some of the sickest patients in need of diabetes care, and a simple mobile health intervention using text messaging can serve as way to bridge the gap between a patient’s urgent visit and finding stable health care, according to a speaker at the American Diabetes Association Scientific Sessions.

SAN FRANCISCO — Among adults with type 2 diabetes and chronic kidney disease, the SGLT2 inhibitor canagliflozin reduced risk for a cardiovascular event or renal failure regardless of prior history of CV disease, according to new subgroup analyses from the CREDENCE trial presented at the American Diabetes Association Scientific Sessions.

Prevalence of nonalcoholic fatty liver disease — and its more severe stage, nonalcoholic steatohepatitis, or NASH, in particular — is increasing in developed countries. The condition has surpassed alcoholism as a cause of cirrhosis and will soon be the primary cause of liver transplantation in the United States, exceeding hepatitis C, according to Kenneth Cusi, MD, FACP, FACE, chief of the division of endocrinology, diabetes and metabolism at University of Florida.

SAN FRANCISCO — Consistently using a continuous glucose monitor may be able to lessen the time spent in hypoglycemia and hyperglycemia for children with type 1 diabetes, but the technology’s impact on time in range may be less substantial, according to findings presented at the American Diabetes Association Scientific Sessions.

Endocrine Today has compiled a list of the top five news reports posted from the American Diabetes Association 79th Scientific Sessions, held June 7-11, 2019, in San Francisco.

SAN FRANCISCO — Adults with type 2 diabetes inadequately controlled with basal insulin therapy alone experienced an improvement in HbA1c and a reduction in total daily basal insulin dose when prescribed a wearable basal-bolus insulin delivery device for 5 months, according to data presented at the American Diabetes Association Scientific Sessions.

SAN FRANCISCO — Having blood pressure of more than 120/80 mm Hg combined with HbA1c of more than 8% makes coronary artery disease three times more likely to manifest for those with type 1 diabetes developed during childhood compared with those with lower measures, according to findings presented at the American Diabetes Association Scientific Sessions.

SAN FRANCISCO — Children and adolescents who develop type 2 diabetes may experience a more aggressive form of the disease that can lead to cardiovascular, kidney, eye, nerve and pregnancy complications as they age, according to findings presented at the American Diabetes Association Scientific Sessions.

Most perioperative adults with diabetes made an unplanned attempt to quit smoking after enrolling in a smoking cessation program led by certified diabetes educators, with more than half reporting reduced smoking after attending the program, according to data presented at the American Diabetes Association Scientific Sessions.

SAN FRANCISCO — Children born to women with an HbA1c of at least 6.5% were nearly twice as likely to receive a diagnosis of autism in the first 4 years of life vs. offspring of mothers with HbA1c below 5.7%, according to a speaker at the American Diabetes Association Scientific Sessions.